Cite
HARVARD Citation
Kalff, A. et al. (2019). Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study). Leukemia & lymphoma. 60 (9), pp. 2143-2151. [Online].